Paroxysmal Nocturnal Hemoglobinuria (PNH) also known as Marchiafava-Micheli Syndrome (named after Dr. Ettore Marchiafava and Dr. Ferdinando Micheli)
For every million people only a few of them will get paroxysmal nocturnal hemoglobinuria which makes this a rare blood disease. Paroxysmal nocturnal hemoglobinuria affects both sexes and all ages equally. Patients with PNH suffer from a faulty or missing PGI-A gene which can be found within the erythrocytes, leukocytes, and thrombocytes. Paroxysmal nocturnal hemoglobinuria is not an inherited disease but is considered an acquired disease because the hematopoietic stem cells over time begin to change and malfunction. This process of cell change is called somatic mutation. Although not all of the blood cells will have this faulty gene the ones that do will only be able to produce more mutated cells creating a cycle of increasing damaged cells that keeps expanding. The number of mutated cells a person with this disease has is what determines the degree to which they will suffer from the symptoms. As the number of PNH cells increases so does the symptoms. The PIG-A gene also plays a part in sending the signals to the body on how to make GPI anchors that secure compliment regulating proteins to blood cell membranes. When these protecting proteins lack the ability to attach they leave the blood cells vulnerable to attack from the body’s own immune system. Without compliment regulating proteins the immune system reacts as if the cells were an infection or bacteria and destroys them. When the body does not have sufficient red blood cells the condition is called hemolytic anemia. PNH also damages platelets (thrombocytes) interfering with the ability to form blood clots, because of th...
... middle of paper ...
...destroys PNH by transplanting healthy marrow (most often from a relative) into the patient. There is a VERY high mortality rate with this cure so generally it is reserved for patients who suffer from PNH along with another disease such as leukemia, aplastic anemia, or myelodysplastic syndrome and all other treatment options are no longer enough.
Works Cited
http://www.ncbi.nlm.nih.gov/books/NBK22166/
http://ghr.nlm.nih.gov/condition/paroxysmal-nocturnal-hemoglobinuria
http://www.nlm.nih.gov/medlineplus/ency/article/003642.htm
http://www.nlm.nih.gov/medlineplus/ency/article/000534.htm
http://en.wikipedia.org/wiki/Paroxysmal_nocturnal_hemoglobinuria#Treatment
http://rarediseases.info.nih.gov/GARD/Disease.aspx?PageID=4&DiseaseID=7337
http://bloodjournal.hematologylibrary.org/content/113/26/6522.full
http://www.haematologica.org/cgi/content/full/95/6/855
... it, which destroys all healthy bone marrow in the body. As a result of this, the patient will have to undergo a process to replace all deteriorated or damaged bone marrow. This process involves taking the stem cells from a donor and transplanting them into the patient’s body, so that the patient will transform these stem cells into bone marrow. Bone marrow can also be a complication for the body if it escapes into the blood stream. If the bone marrow enters the blood stream, it can travel throughout the body, and cause serious complications. This is a condition referred to as fat embolism, and mainly occurs after serious trauma or surgery to lower limbs. There is not a specific diagnosis or treatment for this; it is mostly based on the patient’s condition or symptoms. Bone marrow can be a very dangerous thing if it has any type of complications within the body.
• Hemolytic disease of the newborn. Hemolytic disease happens when a mother 's disease fighting system (immune system) attacks her baby 's red blood cells. Proteins (antibodies) in the mother’s blood destroy the baby 's red blood cells. Two conditions can cause hemolytic disease:
In some individuals with severe hemophilia, the factor VIII replacement therapy is identified as a foreign substance by their immune system. If this happens, their immune system will make antibodies against factor VIII. These antibodies will inhibit the ability of the factor to work in the clotting process. The higher the antibody or inhibitor level, the more factor VIII replacement therapy it takes to overcome the inhibition and produce clotting. This can complicate the treatment of a bleed. The good news is that there are different types of therapies available to successfully treat most individuals who develop inhibitors.
Disease can damage blood marrow and tissue. In order to repair this damage, doctors can transplant the stem cells described above into the patient in need. There are a few different names for this kind of transplant procedure. They are: bone marrow transplant, a peripheral blood stem cell transplant, and a cord blood transplant (American Cancer Society, 2013). The process of transplanting these hematopoietic stem cells involves a number of complex steps. The first step involves the patient receiving chemotherapy and/or radiation, which kill the diseased cells. This “conditions” the area (Dana-Farber Cancer Institute, 2014). Next, healthy stem cells are infused into this conditioned area. “These transplanted stem cells will begin to grow and produce healthy red and white blood cells and platelets” (Dana-Farber Can...
According to the details given in case study, Ms. A has iron deficiency anemia. Iron deficiency anemia is the most common type of anemia. It is a condition where the blood lacks enough red blood cells (Clark, 2008). When there are a low number of red blood cells, it makes transportation of oxygen to parts of the body very difficult. Iron deficiency is type of anemia due to the lack of iron in the body. Without the proper amount of iron in the body, it cannot produce enough hemoglobin and since hemoglobin is the main carrier of oxygen, low levels of it can lead to tiredness and shortness of breath (Copstead, Banasik, 2010).
Sickle Cell is a disease that affects many people in the world today. It is the number one genetic disorder in the United States. Sickle Cell is deficient hemoglobin. Hemoglobin is what functions in providing oxygen to the cells in the body. The sickle shape comes from the atypical hemoglobin s molecules. Hemoglobin molecules are composed of two different parts called the alpha and beta. The beta subunit of the hemoglobin molecule has a mutation in gene, on chromosome 11 which produces the change in the red blood cell shape causing them to die and not reproduce accurately. The change in shape causes the red blood cells to get stuck in the blood vessels and block the effectiveness of oxygen transport causing pain and organ damage to the body. This disease does not have a cure and some common treatments are used to help patients live with the disease. Some treatment options are antibiotics (penicillin) to prevent infections, blood transfusions, folic acid that help produces new blood cells. These are just some of the current treatments for Sickle Cell.
In septic patients, increased levels of PAI-1 inhibit plasminogen activator (t-PA), which converts plasminogen to plasmin. Release of fibrin inhibits fibrinolysis by activation of thrombin-activatable fibrinolysis inhibitor (TAFI). In addition, the release of PAF causes platelet aggregation. This combination of inhibition of fibrinolysis, fibrin strand production and platelet aggregation contribute to a state of coagulopathy. This can lead to microcirculatory dysfunction with isolated or multiple organ dysfunction and cell death. Mr Hertz’s coagulation profile showed a fibrinogen level of 5.6 g/L, indicating that coagulopathies were underway in his system.
Thalassemia is basically a name for similar groups of inherited blood diseases that involve missing or abnormal genes regarding the protein in hemoglobin which is the red blood cells that carry oxygen throughout the body. I will discuss the different types of Thalassemia, how Thalassemia is diagnosed, and the treatments available. I will also discuss the complications and side effects of the treatments, the disease’s causes and effects, and how it is more dominant in some parts of the world than others. Thalassemia is a blood disorder which means the body makes fewer healthy red blood cells and less hemoglobin. Hemoglobin is a protein that carries oxygen throughout the body and having less hemoglobin leads to anemia. Alpha globin and beta globin are the proteins that create Hemoglobin. A defect in the gene that helps control production of alpha or beta goblin leads to Thalassemia. Fewer blood cells leads to anemia, which is the common culprit in Thalassemia.
Bacteria exist everywhere in the environment and have continuous access to the body through the mouth, nose and pores of skin. Further more, many cells age and die daily and their remains must be removed, this is where the white blood cell plays its role.
Individuals who inherited this disease from their parents do not possess the standard hemoglobin that should be contained in RBC. Hemoglobin is a protein present in RBC, which transports oxygen to all parts of the body (National Heart and Blood Institute, 2017). The disease which impairs the hemoglobin’s responsibility, prevents blood cells from receiving the sufficient oxygen, causes RBC to be sickle shaped. Sickle cell disease precedes to several painful health complications such as VOC (vaso- occlusive crises), which are severe pain recurring episodes, that can lead to irreversible organ damage. Sickle cell anemia causes red blood cells to hemolyze continuously through an individual’s lifetime… hemolysis is the breakdown of red blood cells (Krishnamoorthy, et al. 2017). An experimental study was conducted with SCD Townes mice to test a possible solution for sickle cell anemia. Throughout a seven-week span, mice orally conveyed dosages of 100 mg/kg of DMF. DMF known as dimethyl fumarate is small complex molecule and which binds and activates to enhance Nrf2 to enhance Hbf. “Nrf2 is a transcription factor that triggers cytoprotective and antioxidant pathways to limit oxidative damage, inflammation, and increases HbF” (Krishnamoorthy, et al. 2017). Fetal hemoglobin (Hbf) is the hemoglobin present in fetuses; it is responsible for the transportation of oxygen
Severe bleeding. That's what happens when a person has Hemophilia. "More than 25,000 people in the United States have Hemophilia" (Description of Hemophilia 1). "Hemophilia is an inherited deficiency of a blood-clotting factor that results in episodes of dangerous bleeding" (Hemophilia 1). As you read through this essay, you will learn more about the disease. Some characteristics should be. First you will learn about the diagnosis and prognosis of Hemophilia. Second you will learn the causes and incidences of Hemophilia. And finally you will learn about the treatments and ways of life for the people with Hemophilia.
With all genetic disorders, including hemophilia, it is possible for a human to acquire it spontaneously as a result of gene mutation, which is defined as a change of the nucleotide sequence in the genome of an organism. Mutations that result in hemo...
Polycythaemia is a blood disorder defined as an increase in blood erythrocyte concentration. Absolute polycythaemia is where this increase is caused by greater erythrocyte production, determined by measuring the haematocrit level, with one study showing that 83% of sufferers have a haematocrit level of >55%. This should not be confused with relative polycythaemia, caused by a decrease in blood plasma volume often secondary to hypertension. Interestingly, those affected tend to also have increased blood platelet and white cell concentrations, which correlates well with the notion that the disease is caused by a genetic defect in the haematopoietic stem cell population within the bone marrow. Studies have shown the median age of onset to be 60, although a Mayo Clinic study in Olmstead County, Minnesota showed it to be slightly higher, at between 70 and 79 years, with men affected more than women – though the reason behind the gender inequality is currently unknown. In addition, its prevalence within the US is thought to be in the region of 50/100,000. Furthermore, it has long been known that Finnish skier and seven time Olympic champion Eero Mantyranta suffered from the disease, and it is often stated that his success, at least in part, can be put down to his polycythaemia – indeed experiments have shown that it can increase the blood oxygen carrying capacity by up to 50%, an undeniable asset to any endurance athlete. However, the disease can also prove fatal in many cases because the thickened blood increases the probability of clot formation, giving deep vein thrombosis and potentially pulmonary embolus. It is this double edged nature of polycythaemia that first took ...
Thalassemia is a blood disorder transferred through families. It occurs when the body makes less hemoglobin than needed or an unusual form of hemoglobin. Hemoglobin is the protein in red blood cells that carry oxygen. The disorder makes an excessive amount of destruction of red blood cells. This eventually leads to anemia.
in Hematology on a regular basis, but there were still things I learned by going through